Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam, RXi, IBM, and More


Title: Sustained-release Nucleic Acid Matrix Compositions

Patent Number: 8,795,726

Filed: Jan. 18, 2011

Lead Inventor: Noam Emanuel, Polypid

Title: Hydrophobic Nanotubes and Nanoparticles as Transporters for the Delivery of Drugs into Cells

Patent Number: 8,795,734

Filed: Aug. 3, 2012

Lead Inventor: Hongjie Dai, Stanford University

Title: Ribonucleic Acid Interference Molecules of Oryza sativa

Patent Number: 8,795,987

Filed: July 31, 2008

Lead Inventor: Tien Huynh, IBM

Title: Primer Extension-based Method for the Generation of siRNA/miRNA Expression Vectors

Patent Number: 8,795,988

Filed: Aug. 15, 2008

Lead Inventor: Lin Liu, Oklahoma State University

Title: RNA Interference-mediating Small RNA Molecules

Patent Number: 8,796,016

Filed: June 21, 2010

Lead Inventor: Thomas Tuschl, Max Planck Institute

Title: Methods for Attenuating Dengue Virus Infection

Patent Number: 8,796,235

Filed: Sept. 10, 2004

Lead Inventor: Shyam Mohapatra, University of South Florida

Title: Short RNA Mimetics

Patent Number: 8,796,238

Filed: Sept. 13, 2010

Inventor: Kevin Forbes, Sigma-Aldrich

Title: siRNA Compounds Comprising Terminal Substitutions

Patent Number: 8,796,239

Filed: Nov. 25, 2010

Inventor: Sharon Avkin-Nachum, Quark Pharmaceuticals

Title: Modified iRNA Agents

Patent Number: 8,796,436

Filed: March 22, 2013

Lead Inventor: Muthiah Manoharan, Alnylam Pharmaceuticals

Title: Combined Hairpin-Antisense Compounds and Methods for Modulating Expression

Patent Number: 8,796,442

Filed: March 20, 2008

Lead Inventor: John Shanklin, Brookhaven National Laboratory

Title: Reduced-size Self-delivering RNAi Compounds

Patent Number: 8,796,443

Filed: Sept. 22, 2009

Lead Inventor: Anastasia Khvorova, RXi Pharmaceuticals

Title: Methods and Compositions for the Specific Inhibition of Gene Expression by Double-stranded RNA

Patent Number: 8,796,444

Filed: July 6, 2011

Lead Inventor: John Rossi, City of Hope

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.